OverviewChartNewsTraderScreen

BVT Put 120 6MK 20.09.2024/  DE000VM73BE3  /

Frankfurt Zert./VONT
23/05/2024  10:21:59 Chg.+0.005 Bid11:27:17 Ask11:27:17 Underlying Strike price Expiration date Option type
0.161EUR +3.21% 0.161
Bid Size: 13,000		 0.172
Ask Size: 13,000		 MERCK CO. D... 120.00 - 20/09/2024 Put
GlobeNewswire 22/05 Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
GlobeNewswire 22/05 Invivyd Elects Two New Independent Members to its Board of Directors
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 06/05 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 02/05 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 25/04 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 02/04 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 06/03 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 04/03 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02/02 Merck Group to expand investment in South Korea
TeleTrader 01/02 Merck's Q4 sales up 6% to $14.6B
TeleTrader 27/01 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 23/01 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 21/12/2023 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 19/12/2023 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...
GlobeNewswire 14/12/2023 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire 12/12/2023 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...
GlobeNewswire 05/12/2023 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...
GlobeNewswire 04/12/2023 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire 13/11/2023 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
TeleTrader 26/10/2023 Merck's Q3 sales up 7% to $16B
TeleTrader 20/10/2023 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 17/10/2023 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
GlobeNewswire 28/09/2023 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
GlobeNewswire 26/09/2023 Vaccinex Reports Groundbreaking Findings at Medical Conferences Supporting Development of Pepinemab ...